Precision Wealth Strategies’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,318
Closed -$324K 96
2023
Q3
$324K Buy
+1,318
New +$361K 0.35% 50
2023
Q1
Sell
-1,649
Closed -$396K 87
2022
Q4
$396K Sell
1,649
-7
-0.4% -$1.57K 0.41% 52
2022
Q3
$348K Sell
1,656
-70
-4% -$13.9K 0.31% 75
2022
Q2
$292K Buy
1,726
+138
+9% +$29.6K 0.23% 103
2022
Q1
$398K Sell
1,588
-1,237
-44% -$311K 0.24% 89
2021
Q4
$726K Buy
2,825
+476
+20% +$116K 0.52% 47
2021
Q3
$570K Buy
2,349
+922
+65% +$225K 0.44% 51
2021
Q2
$295K Buy
+1,427
New +$291K 0.25% 79

Other funds holding HCA

Precision Wealth Strategies's HCA Position: Q4 2023 in Review

Precision Wealth Strategies sold out of HCA Healthcare (HCA) in Q4 2023, closing a stake of 1,318 shares — an estimated $324K sold.

Precision Wealth Strategies first reported a position in HCA in Q2 2021 and held it in 8 quarters. The position peaked at $726K in Q4 2021. 1,056 funds tracked by Wall St. Rank hold HCA as of Q4 2023.

  • Precision Wealth Strategies reported no remaining HCA Healthcare position as of Q4 2023 after selling out during the quarter.
  • Precision Wealth Strategies sold 1,318 HCA Healthcare shares in Q4 2023, an estimated $324K.
  • Precision Wealth Strategies first reported a position in HCA Healthcare in Q2 2021 and held it in 8 quarters.
  • Precision Wealth Strategies's HCA Healthcare position peaked at $726K in Q4 2021.
  • 1,056 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2023.

Based on Precision Wealth Strategies's 13F filing for Q4 2023, filed 5 Feb 2024.